| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/17/1994 | WO1994005289A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 03/17/1994 | WO1994005288A1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 03/17/1994 | WO1994005287A1 Prevention or treatment of sepsis with dantrolene or azumolene |
| 03/17/1994 | WO1994005286A1 Ready-to-inject azosemide solutions |
| 03/17/1994 | WO1994005285A1 Metallo porphyrin compositions |
| 03/17/1994 | WO1994005284A1 7-((substituted)amino)-8-(((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes useful in parkinson's disease, dystonia, and other movement disorders |
| 03/17/1994 | WO1994005283A1 Anti-hiv drug |
| 03/17/1994 | WO1994005280A1 Compositions containing dimethylsulphoxide and a sulphydryl group releasing agent |
| 03/17/1994 | WO1994005279A1 Dermatological treatment compositions containing dimethylsulphone and a sulfur containing amino acid |
| 03/17/1994 | WO1994005278A1 X-hydroxy saturated fatty acids for the treatment of corns and calluses |
| 03/17/1994 | WO1994005277A1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
| 03/17/1994 | WO1994005275A1 Method of preventing nmda receptor-mediated neuronal damage |
| 03/17/1994 | WO1994005274A1 Glycation inhibitor |
| 03/17/1994 | WO1994005273A1 Gastrointestinal compositions containing dimethylsulfone and dimethylsulfoxide |
| 03/17/1994 | WO1994005272A1 Skin treatment compositions containing dimethylsulphone and dimethylsulphoxide |
| 03/17/1994 | WO1994005271A1 Gastrointestinal cancer therapy composition containing dimethylsulphone and dimethylsulphoxide |
| 03/17/1994 | WO1994005270A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass |
| 03/17/1994 | WO1994005269A1 Peptide inhibitors of selectin binding |
| 03/17/1994 | WO1994005267A2 Use of carrageenans as growth factor antagonists |
| 03/17/1994 | WO1994005265A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 03/17/1994 | WO1994005263A1 Beads having a core coated with an antifungal and a polymer |
| 03/17/1994 | WO1994005262A1 Sustained release matrix composition |
| 03/17/1994 | WO1994005258A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof |
| 03/17/1994 | WO1994005255A1 Skin moisturizer compositions containing dimethylsulphydryl group releasing agent |
| 03/17/1994 | WO1994005250A1 Synergistic compositions for hair restoration containing dimethylsulfone and a sulphydryl group releasing agent |
| 03/17/1994 | WO1994005156A1 Combination of germicidal agents |
| 03/17/1994 | WO1994005152A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
| 03/17/1994 | WO1994002586A3 Repression of virulent gene expression |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | WO1993025568A3 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
| 03/17/1994 | WO1993017020A3 Therapeutic nucleosides |
| 03/17/1994 | EP0585366A4 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood. |
| 03/17/1994 | DE4231085A1 VPA-analoge Antiepileptika VPA-analog antiepileptic drugs |
| 03/17/1994 | DE4230902A1 5,6-benzo-alpha-pyrone for chronic kidney insufficiency treatment - partic effective if combined with a protein restrictive diet. |
| 03/17/1994 | DE4230755A1 Phosphodiesterase IV inhibitors for kidney and ureter disease treatment - with eg (4-(3-(cyclopentyl oxy) 4-methoxyphenyl-2-pyrrolidinone) being specific for kidney and ureter tissue relaxation |
| 03/17/1994 | DE4230493A1 Use of Evans blue as AMPA-kainate receptor antagonists - esp. for treating CNS disorders |
| 03/17/1994 | CA2273147A1 Substituted thiazolidinedione derivatives |
| 03/17/1994 | CA2144423A1 Heteroaryl compounds used as pharmaceuticals |
| 03/17/1994 | CA2144166A1 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules elam-1 (e-selectin) and lecam-1 (l-selectin) |
| 03/17/1994 | CA2144051A1 New fullerene derivatives, method of synthesizing them and their use |
| 03/17/1994 | CA2143834A1 Antiviral pyrimidine nucleosides |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143744A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents |
| 03/17/1994 | CA2143688A1 Transdermal therapeutic system with pentylene tetrazol as active substance |
| 03/17/1994 | CA2143678A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | CA2143629A1 X-hydroxy saturated fatty acids for the treatment of corns and calluses |
| 03/17/1994 | CA2143449A1 Optically active carboxamide derivative |
| 03/17/1994 | CA2143430A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 03/17/1994 | CA2143207A1 4-hydroxy coumarin derivatives with antibacterial activity |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2143010A1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
| 03/17/1994 | CA2142708A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents |
| 03/17/1994 | CA2142493A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-¬(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof |
| 03/17/1994 | CA2142348A1 Phosphono substituted tetrazole derivatives |
| 03/17/1994 | CA2142278A1 New isoindolinone derivative; process for preparing the same and pharmaceutical compositions containing it |
| 03/17/1994 | CA2142275A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use |
| 03/17/1994 | CA2141965A1 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds |
| 03/17/1994 | CA2141935A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | CA2141863A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/17/1994 | CA2141425A1 Nitrogen substituted acridine and cytochrome p450 inhibitors and methods of use |
| 03/17/1994 | CA2140930A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin) |
| 03/17/1994 | CA2140920A1 Combination of germicidal agents |
| 03/17/1994 | CA2122342A1 Pharmaceutical composition |
| 03/17/1994 | CA2120956A1 New amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 03/17/1994 | CA2120341A1 4,5-dicyanoimidazole derivatives and pesticidal compositions containing them |
| 03/17/1994 | CA2078375A1 Anti headache and pain hair/bath shampoo |
| 03/16/1994 | EP0587499A1 Benzopyran compounds, process for their preparation and their use as cell protectors |
| 03/16/1994 | EP0587476A1 Compositions containing mono or polyhydroxylated amino acids for the treatment of non-insulin dependent diabetes mellitus |
| 03/16/1994 | EP0587473A1 Condensed pyridine derivatives as inhibitors of the effects of free radicals |
| 03/16/1994 | EP0587436A1 Process for preparing carbapenem and penem compounds and new compounds involved in that process |
| 03/16/1994 | EP0587396A1 Use of hypoxoside derivatives for the treatment of viral infections |
| 03/16/1994 | EP0587378A1 Prevention of bone resorption |
| 03/16/1994 | EP0587377A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease |
| 03/16/1994 | EP0587374A2 Sulfated sterol glycosides and their use against viral infections. |
| 03/16/1994 | EP0587264A1 Aqueous pharmaceutical formulations of sodium cromoglycate |
| 03/16/1994 | EP0587194A1 2-(Heterocycloalkoxy)-1-(subst.-phenyl)-ethanol derivatives as cerebral function improving agents |
| 03/16/1994 | EP0587193A1 1,2-Ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/16/1994 | EP0587188A2 Aryl and heterocyclic substituted propenamide derivatives |
| 03/16/1994 | EP0587180A2 Aryl urea (Thiourea) and cyanoguanidine derivatives |
| 03/16/1994 | EP0587137A1 Adsorbate comparised of an auxiliary agent mixture and a non-solid active agent for the manufacture of pharmaceutical preparations |
| 03/16/1994 | EP0587135A1 Enhanced chemotherapeutic compositions against microbial infections in fish contaning a benzylamine derivative and an antimicrobial substance |
| 03/16/1994 | EP0587134A2 Cyclic urea derivatives, medicaments containing them and process for their preparation |
| 03/16/1994 | EP0587121A1 Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof |
| 03/16/1994 | EP0587101A2 Apparatus for the removal of aluminium ions from blood and solution used in this apparatus |
| 03/16/1994 | EP0587088A1 Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases |
| 03/16/1994 | EP0587087A1 Substituted cyclohexane derivatives for the treatment of diseases |
| 03/16/1994 | EP0587065A1 Programmed release tablets containing naproxen |
| 03/16/1994 | EP0587048A2 Heteroarenylpiperazines, a process for their preparation and their use as medicaments |
| 03/16/1994 | EP0587047A2 Gestagenes containing pharmaceutical composition |
| 03/16/1994 | EP0586961A1 Cosmetic and dermatologic formulations containing an effective amount of cis urocanic acid |
| 03/16/1994 | EP0586960A1 Xanthone derivatives, their preparation and use |
| 03/16/1994 | EP0586917A1 Substituted phenols, process for their preparation and their use in the treatment of all proliferation associated diseases |
| 03/16/1994 | EP0586866A2 1,4,-Benzodioxane derivatives with pharmacologic properties |
| 03/16/1994 | EP0586806A1 Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation |
| 03/16/1994 | EP0586738A1 Enhanced chemotherapeutic compositions against microbial infections in fish containing a benzylamine derivative and an antimicrobial substance |
| 03/16/1994 | EP0586663A1 Carbapenem derivatives as antibiotics and intermediates thereof |
| 03/16/1994 | EP0586632A1 Benzodiazepinones and medicines containing them |
| 03/16/1994 | EP0586621A1 Linsidomin for treating erectile dysfunctions |